tiprankstipranks
Trending News
More News >
Mitsui Chemicals Inc (JP:4183)
:4183

Mitsui Chemicals (4183) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4183

Mitsui Chemicals

(4183)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 4o)
Rating:64Neutral
Price Target:
¥4,097.00
▲(6.86% Upside)
Mitsui Chemicals' stock score is primarily influenced by its stable financial performance and technical indicators, which suggest a neutral to slightly bullish outlook. However, the high P/E ratio indicates overvaluation, which could limit growth potential. The attractive dividend yield provides some compensation for valuation concerns. The absence of earnings call and corporate events data means these factors did not influence the score.
Positive Factors
Business Model Strength
The focus on high-value-added products supports margin sustainability and competitive advantage, enhancing long-term profitability.
Market Position
Diverse sector operations provide resilience against market fluctuations, supporting stable revenue streams and long-term growth.
Balance Sheet Health
A balanced debt-to-equity ratio indicates financial stability, allowing for strategic investments and growth opportunities.
Negative Factors
Revenue Growth Trends
Declining revenue growth suggests potential market challenges, which could impact long-term expansion and market share.
Margin Sustainability
Decreasing net profit margins highlight challenges in maintaining profitability, potentially affecting long-term financial health.
Cash Generation Ability
Declining free cash flow growth limits the ability to fund future investments, impacting growth and strategic initiatives.

Mitsui Chemicals (4183) vs. iShares MSCI Japan ETF (EWJ)

Mitsui Chemicals Business Overview & Revenue Model

Company DescriptionMitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyMitsui Chemicals generates revenue through multiple streams, primarily from the sale of its chemical and polymer products to various industries. The company focuses on high-value-added products, which tend to offer better margins. Key revenue streams include functional chemicals, such as adhesives and coatings, performance materials like engineering plastics and films, and agricultural chemicals. Mitsui Chemicals also engages in strategic partnerships and joint ventures with other companies to enhance its market reach and develop new technologies. Additionally, the company invests in research and development to innovate and improve its product offerings, which contributes to its competitive advantage and overall earnings.

Mitsui Chemicals Earnings Call Summary

Earnings Call Date:Feb 04, 2025
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Feb 11, 2026
Earnings Call Sentiment Negative
The earnings call highlighted some positive aspects such as growth in the Mobility Solutions segment and improvements in terms of trade. However, these were overshadowed by significant declines in overall sales and profits, challenges in key segments such as Basic & Green Materials and ICT Solutions, and a downward revision of the full-year forecast.
Q3-2024 Updates
Positive Updates
Mobility Solutions Growth
Mobility Solutions reported an operating income before special items of JPY 41.0 billion, an increase of JPY 2.1 billion compared to the same period last year. This was driven by growth in solar cell encapsulation materials and the recovery in automotive applications. The terms of trade were also positive, reflecting exchange rate differences and a shift to high value-added products.
Improvement in Terms of Trade
Terms of trade improved by JPY 4.2 billion in Life & Healthcare Solutions, JPY 4.6 billion in Mobility Solutions, and JPY 4.4 billion in ICT Solutions due to price hikes, yen depreciation, and lower raw material prices.
Positive Free Cash Flow
For the full year 2023, cash flows from operating activities are expected to be positive JPY 130.0 billion, resulting in a positive free cash flow of JPY 24.0 billion.
Negative Updates
Overall Decline in Sales and Profits
Sales revenue for the April to December period was JPY 1.2745 trillion, a decrease of JPY 154.4 billion compared to the same period last year. Operating income before special items was JPY 72.4 billion, a decrease of JPY 37.9 billion, and net income was JPY 37.3 billion, a decrease of JPY 27.6 billion.
Significant Decline in Basic & Green Materials
Basic & Green Materials posted an operating income before special items of negative JPY 3.9 billion, a significant decrease of JPY 33.7 billion compared to the same period last year, due to lower sales and the elimination of inventory valuation gains.
Challenges in ICT Solutions
ICT Solutions experienced a decrease in operating income before special items by JPY 4.9 billion due to the slowdown in demand in the semiconductor and smartphone markets.
Adjusted Downward Forecast for FY 2023
The forecast for FY 2023 operating income before special items was revised downward from JPY 112.0 billion to JPY 93.0 billion due to sluggish demand recovery, lower cracker utilization rates, and business restructuring losses.
Company Guidance
During the third quarter earnings call for Mitsui Chemicals, CFO Nakajima detailed a challenging financial period marked by sluggish demand and declining raw material prices, leading to a year-on-year decrease in both sales and profits. Operating income before special items was revised downward from JPY 112.0 billion to JPY 93.0 billion, attributed to slower-than-expected demand recovery and lower cracker utilization rates. Net income forecast was also reduced to JPY 50.0 billion, factoring in business restructuring losses. Despite these setbacks, the annual dividend forecast remains at JPY 140 per share. In terms of business segments, Life & Healthcare Solutions saw a decrease in operating income to JPY 18.5 billion, while Mobility Solutions experienced a slight increase to JPY 41.0 billion. ICT Solutions faced a drop to JPY 18.1 billion, and Basic & Green Materials posted a negative JPY 3.9 billion. The financial outlook for FY 2023 expects sales revenue to decrease to JPY 1.741 trillion, with an anticipated operating income of JPY 93.0 billion. The exchange rate assumption is set at JPY 144 to the U.S. dollar, with domestic naphtha prices projected at JPY 71,900 per kiloliter in the second half. Despite these challenges, the company anticipates profit growth in the Mobility segment, driven by solar cell encapsulation materials and recovery in automobile production.

Mitsui Chemicals Financial Statement Overview

Summary
Mitsui Chemicals demonstrates stable financial management with consistent gross margins and a solid balance sheet. However, declining profitability and negative revenue growth indicate challenges in market expansion and operational efficiency. Cash flow generation is strong, providing a buffer against profitability pressures.
Income Statement
65
Positive
Mitsui Chemicals shows a stable gross profit margin around 21%, indicating consistent cost management. However, the net profit margin has decreased to 1.78% in the TTM, reflecting reduced profitability. Revenue growth is negative at -1.89% in the TTM, suggesting challenges in expanding sales. The EBIT and EBITDA margins have also declined, indicating pressure on operational efficiency.
Balance Sheet
70
Positive
The company's debt-to-equity ratio is stable at approximately 0.87, indicating moderate leverage. Return on equity has decreased to 3.72% in the TTM, showing reduced profitability for shareholders. The equity ratio remains healthy, suggesting a solid capital structure.
Cash Flow
60
Neutral
Operating cash flow has improved, with a positive free cash flow growth rate of 12.86% in the TTM. The operating cash flow to net income ratio is strong, indicating good cash generation relative to earnings. However, the free cash flow to net income ratio is moderate, suggesting room for improvement in cash flow efficiency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.73T1.81T1.75T1.88T1.61T1.21T
Gross Profit377.26B388.29B370.80B381.49B378.74B293.84B
EBITDA152.62B186.12B183.24B197.27B204.58B150.44B
Net Income17.86B32.24B50.00B82.94B109.99B57.87B
Balance Sheet
Total Assets2.10T2.15T2.22T2.07T1.93T1.56T
Cash, Cash Equivalents and Short-Term Investments198.75B209.23B210.29B186.31B181.15B195.99B
Total Debt696.42B737.98B756.76B738.25B666.09B510.22B
Total Liabilities1.12T1.18T1.23T1.18T1.13T875.97B
Stockholders Equity854.37B848.28B862.85B786.83B712.65B607.92B
Cash Flow
Free Cash Flow82.72B62.09B7.35B-36.62B-23.63B97.74B
Operating Cash Flow209.74B200.50B161.34B101.24B92.58B174.32B
Investing Cash Flow-176.71B-165.01B-123.94B-106.34B-205.23B-77.56B
Financing Cash Flow-40.38B-74.44B-26.02B2.54B89.22B-68.96B

Mitsui Chemicals Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3834.00
Price Trends
50DMA
3727.52
Positive
100DMA
3652.12
Positive
200DMA
3415.63
Positive
Market Momentum
MACD
48.99
Positive
RSI
52.37
Neutral
STOCH
28.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4183, the sentiment is Neutral. The current price of 3834 is below the 20-day moving average (MA) of 3846.95, above the 50-day MA of 3727.52, and above the 200-day MA of 3415.63, indicating a neutral trend. The MACD of 48.99 indicates Positive momentum. The RSI at 52.37 is Neutral, neither overbought nor oversold. The STOCH value of 28.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4183.

Mitsui Chemicals Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥362.83B10.089.34%4.44%-0.48%-35.29%
75
Outperform
¥764.00B21.7112.15%1.55%2.62%2.81%
74
Outperform
¥272.31B10.325.47%3.48%2.60%9.50%
67
Neutral
¥1.11T21.313.63%4.04%-1.17%
64
Neutral
¥736.77B40.982.02%3.92%-4.63%-65.11%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
$553.56B-73.86-1.15%3.56%-6.83%-123.67%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4183
Mitsui Chemicals
3,829.00
630.36
19.71%
JP:5201
AGC
5,201.00
853.38
19.63%
JP:4202
Daicel
1,352.50
58.75
4.54%
JP:4118
Kaneka
4,281.00
761.58
21.64%
JP:4182
Mitsubishi Gas Chemical Company
2,808.00
219.71
8.49%
JP:4403
NOF
3,234.00
1,110.55
52.30%

Mitsui Chemicals Corporate Events

Mitsui Chemicals Announces Stock Split and Dividend Revision
Nov 11, 2025

Mitsui Chemicals, Inc. announced a two-for-one stock split to make its shares more affordable and expand its investor base. The company also revised its dividend forecast in line with the stock split, although there is no effective change from the previous forecast, indicating a strategic move to maintain shareholder value.

Mitsui Chemicals Reports Decline in First Half FY2025 Financial Results
Nov 11, 2025

Mitsui Chemicals reported a decline in sales revenue and operating income for the first half of FY2025 compared to the previous year. The company has undergone organizational reforms and segment revisions, impacting its financial performance. Despite the challenges, certain segments like ICT solutions showed growth, while others like basic & green materials experienced significant declines. The company also announced a two-for-one stock split, affecting dividend forecasts.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025